However, future studies of circulating basophils in cancer may benefit from the inclusion of additional markers for basophil identification (such as CD203c, CD123, and CRTH2), and basophil activation (such as CD203c, CD107a, CD13, CD164, CD69, and histamine or tryptase release) [9,42]. The gene discussed is LAMP1; the disease is cancer.